Concepedia

Kubilay Karaboyun

KK

Statistics

Publications

3

Citations

60

H-Index

3

Active since

2022

Affiliations

Tekirdağ Namık Kemal University(Current)

Istanbul University

Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi

Dokuz Eylül University

Amerikan Hastanesi

Kubilay Karaboyun is an author at Tekirdağ Namık Kemal University specializing in oncology, chemotherapy, and chemotherapy toxicity risk assessment.

ORCID

Publications per year

2022–2023

3

Publications

3

Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer

Eyyüp Çavdar, Yakup İriağaç, Kubilay Karaboyun et al. · Journal of Geriatric Oncology · 2022 · 25 citations

, , +14

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Cengiz Karaçin, Berna Öksüzoğlu, Ayşe Demirci et al. · BMC Cancer · 2023 · 23 citations · Full text

, , +13

PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

Okan Avcı, Yakup İriağaç, Eyyüp Çavdar et al. · Journal of Geriatric Oncology · 2023 · 12 citations · Full text

, , +10

1–3 of 3